Explore key messages and supporting factoids about the Greater Philadelphia Region’s leadership in Cell and Gene Therapy and Connected Health in this one-sheet document.
The Cell and Gene Therapy and Connected Health Tool Kit is a living resource centered on the Greater Philadelphia region’s past, present and future as a hub for cell and gene therapy and connected health.
The leaders behind some of the most successful biotech companies in the country have chosen to grow their businesses in Philadelphia because, even when compared to Silicon Valley, Philadelphia has the most to offer, they say.
Philadelphia-based ExpressCells, Inc. (ExpressCells)
Dr. James Wilson and his team at Penn Medicine are celebrating the U.S. Food and Drug Administration (FDA) of a gene therapy known as Zolgensma for Spinal Muscular Atrophy, based on a delivery vehicle that his team discovered and developed over the past decade as part of a wide-ranging portfolio of research to advance gene therapy.
Cancer-therapy firm Iovance Biotherapeutics Inc. plans to open a sprawling office and laboratory complex in South Philadelphia’s Navy Yard complex, adding to the city’s growing clout as a biotechnology research-and-development hub.
Spark Therapeutics Inc., founded by researchers from Children’s Hospital of Philadelphia agreed to be sold to Switzerland-based Roche Holding AG for $4.3 billion.